Prospective controlled clinical and histopathologic study of hidradenitis suppurativa treated with the long-pulsed neodymium:yttrium-aluminium-garnet laser

作者: Bassel H. Mahmoud , Emily Tierney , Camile L. Hexsel , John Pui , David M. Ozog

DOI: 10.1016/J.JAAD.2009.07.048

关键词: SurgeryHidradenitis suppurativaMedicineIntertriginousBenzoyl peroxideHistopathologyRandomized controlled trialLaserClindamycinPatient satisfaction

摘要: Background Hidradenitis suppurativa (HS) is a chronic inflammatory disease involving the intertriginous areas. Objective We sought to conduct clinical and histopathologic evaluation of efficacy long-pulsed neodymium:yttrium-aluminium-garnet laser treatment for HS. Methods conducted prospective, randomized, right-left within-patient controlled trial HS (n = 22). Four monthly sessions were performed. Disease activity was measured at baseline, response assessed before each session 2 months after completion treatment, using modified scoring system based on Sartorius score. Histologic examination performed immediately 1 4 weeks treatment. A patient questionnaire circulated last visit assess patients' level satisfaction. Results There progressive improvement in activity, most significantly during 4 months which maintained 2-month posttreatment follow-up period. Averaged over all anatomic sites, percent 72.7% treated side, 22.9% control side ( P Limitations Small sample size limitation. Conclusions Long-pulsed laser, together with topical benzoyl peroxide clindamycin, more effective than clindamycin alone Preliminary review histopathology suggests mechanism action destruction hair follicle. The overall success both clearing pre-existing lesions preventing new eruptions, coupled high satisfaction, makes promising advance this highly disabling condition.

参考文章(28)
Tancy M Bridges, Molly Boring, Virginia Lee Bradshaw, Michael Gold, ALA-PDT and blue light therapy for hidradenitis suppurativa. Journal of Drugs in Dermatology. ,vol. 3, ,(2004)
S Rogers, D A Buckley, Cyclosporin-responsive hidradenitis suppurativa. Journal of the Royal Society of Medicine. ,vol. 88, ,(1995)
A.M.G. Brunasso, C. Delfino, C. Massone, Hidradenitis suppurativa: are tumour necrosis factor‐α blockers the ultimate alternative? British Journal of Dermatology. ,vol. 159, pp. 761- 763 ,(2008) , 10.1111/J.1365-2133.2008.08735.X
Gregor B.E. Jemec, Peter Wendelboe, Topical clindamycin versus systemic tetracycline in the treatment of hidradenitis suppurativa Journal of The American Academy of Dermatology. ,vol. 39, pp. 971- 974 ,(1998) , 10.1016/S0190-9622(98)70272-5
J.S. FITZSIMMONS, P.R. GUILBERT, E.M. FITZSIMMONS, Evidence of genetic factors in hidradenitis suppurativa British Journal of Dermatology. ,vol. 113, pp. 1- 8 ,(1985) , 10.1111/J.1365-2133.1985.TB02037.X
B J Harrison, M Mudge, L E Hughes, Recurrence after surgical treatment of hidradenitis suppurativa. BMJ. ,vol. 294, pp. 487- 489 ,(1987) , 10.1136/BMJ.294.6570.487
H. Lévesque, N.D. Manchon, N. Moore, H. Courtois, C. Trivalle, J.P. Vinel, J. Hémet, E. Bercoff, J. Bourreille, FULMINANT HEPATITIS DUE TO CYPROTERONE ACETATE The Lancet. ,vol. 333, pp. 215- 216 ,(1989) , 10.1016/S0140-6736(89)91225-7
Rainer Rompel, Johannes Petres, Long-term results of wide surgical excision in 106 patients with hidradenitis suppurativa. Dermatologic Surgery. ,vol. 26, pp. 638- 643 ,(2000) , 10.1046/J.1524-4725.2000.00043.X
Jurr Boer, Mirjan J.P. van Gemert, Long-term results of isotretinoin in the treatment of 68 patients with hidradenitis suppurativa Journal of The American Academy of Dermatology. ,vol. 40, pp. 73- 76 ,(1999) , 10.1016/S0190-9622(99)70530-X